PAI-1 4G/5G polymorphism contributes to cancer susceptibility: evidence from meta-analysis.
BACKGROUND: The plasminogen activator inhibitor-1 (PAI-1) is expressed in many cancer cell types and allows the modulation of cancer growth, invasion and angiogenesis. To date, studies investigated the association between a functional polymorphism in PAI-1 (4G/5G) and risk of cancer have shown inclu...
Main Authors: | Shangqian Wang, Qiang Cao, Xiaoxiang Wang, Bingjie Li, Min Tang, Wanqing Yuan, Jianzheng Fang, Jian Qian, Chao Qin, Wei Zhang |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2013-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC3577655?pdf=render |
Similar Items
-
PAI-1 -675 4G/5G polymorphism in association with diabetes and diabetic complications susceptibility: a meta-analysis study.
by: Kuanfeng Xu, et al.
Published: (2013-01-01) -
Association between MMP-1 g.-1607dupG polymorphism and periodontitis susceptibility: a meta-analysis.
by: Dandan Li, et al.
Published: (2013-01-01) -
The G Allele of CaSR R990G Polymorphism Increases Susceptibility to Urolithiasis and Hypercalciuria: Evidences from a Comprehensive Meta-Analysis
by: Kang Liu, et al.
Published: (2015-01-01) -
Association between FEN1 Polymorphisms -69G>A and 4150G>T with Susceptibility in Human Disease: A Meta-Analysis
by: Nanjiao YING, et al.
Published: (2015-12-01) -
Association between the -844 G>A, HindIII C>G, and 4G/5G PAI-1 Polymorphisms and Susceptibility to Multiple Sclerosis in Western Mexican Population
by: Emmanuel Valdés-Alvarado, et al.
Published: (2019-01-01)